Tytti
Vuorinen
Adjunct Professor, Institute of Biomedicine
Docent, Institute of Biomedicine

Contact

Kiinamyllynkatu 13
20520
Turku

Areas of expertise

Clinical Virology
Medical Microbiology
CNS and respiratory virus infections

Biography

Doctor of Medical Sciences (PhD), Department of Virology, Faculty of Medicine, University of Turku 1996, 

 Specialist in Clinical Microbiology, Faculty of Medicine, University of Turku2002

Docent in Virology, University of Turku 2005

Special competence in medical education, Finnish Medical Association 2009

Pedagogical studies for university teacher (60 ects) , Faculty of Education, University of Turku 2012

Head of virus diagnostic laboratory, University of Turku 2009-2015,

Chief physician Medical MIcrobiology, Turku University Hospital 2015-

Activities in the Medical Faculty: Vice Chair, Department of Microbiology and Pathology 2008-2010

                      Member  of a sub-committee for developing professional education in medicine,    2000-2005

                      Member of a developing education taskforce for undergraduates in dentistry, 2003-2007

                      Quality assurance supervisor, Institute of Microbiology and Pathology, 2005-2010  

Teaching

I have been involved in teaching medical students since I started my carrier at the department of Virology. During my carrier as a teacher, I have realized that  learning is a continuous lifetime process and I have tried to adopte more cognitive and constructive models of learning and teaching. 

I have participated in development of PBL teaching in medical microbiology and setting up a teacher tutor system in medical faculty. I have written a guide for teachers about tutoring of students. I have published one pedagogic peer-reviewed article in Finnish.

   

Research

My scientific interest due to my background of medical education is mainly based on viral pathogenesis and clinical virology. My special interest has been on Picornaviruses, which are important human pathogens. Enteroviruses cause respiratory infections, meningitis, encephalitis and myocarditis and rhinoviruses are the most common cause of common cold. Viral infections in wheezing children have been one major clinical project with international collaboration. On this field we have published several important findings (e.g. efficacy of prednisolon in early wheezing caused by rhinoviruses, the first wheezing episode with rhinovirus predict later ashtma development, hyperactive immune response in asthmatics to repeated rhinovirus infection). 

Publications

Sort by:

Burden of influenza during the first year of life (2021)

Influenza and Other Respiratory Viruses
Mattila Janna‐Maija, Thomas Emilia, Lehtinen Pasi, Vuorinen Tytti, Waris Matti, Heikkinen Terho
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

IL-6 and other biomarkers as predictors of severity in COVID-19 (2021)

Annals of Medicine
Broman N, Rantasärkkä K, Feuth T, Valtonen M, Waris M, Hohenthal U, Rintala E, Karlsson A, Marttila H, Peltola V, Vuorinen T, Oksi J
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021 (2021)

Emerging Infectious Diseases
Kant Ravi, Nguyen Phuoc Truong, Blomqvist Soile, Erdin Mert, Alburkat Hussein, Suvanto Maija, Zakham Fathiah, Salminen Veera, Olander Viktor, Paloniemi Minna, Huhti Leena, Lehtinen Sara, Luukinen Bruno, Jarva Hanna, Kallio-Kokko Hannimari, Kurkela Satu, Lappalainen Maija, Liimatainen Hanna, Hannula Sari, Halkilahti Jani, Ikonen Jonna, Ikonen Niina, Helve Otto, Gunell Marianne, Vuorinen Tytti, Plyusnin Ilya, Lindh Erika, Ellonen Pekka, Sironen Tarja, Savolainen-Kopra Carita, Smura Teemu, Vapalahti Olli
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Molecular epidemiology and evolutionary trajectory of emerging echovirus 30, Europe (2021)

Emerging Infectious Diseases
Benschop Kimberley S.M., Broberg Eeva, Hodcroft Emma, Schmitz Dennis, Albert Jan, Baicus Anda, Bailly Jean,Luc, Baldvinsdottir Gudrun, Berginc Natasa, Blomqvist Soile, Böttcher Sindy, Brytting Mia, Bujaki Erika, Cabrerizo Maria, Celma Cristina, Cinek Ondrej, Claas Eric C.J., Cremer Jeroen, Dean Jonathan, Dembinski Jennifer, Demchyshyna Iryna, Diedrich Sabine, Dudman Susanne, Dunning Jake, Dyrdak Robert, Emmanouil Mary, Farkas Agnes, De Gascun Cillian, Fournier Guillme, Georgieva Irina, Gonzalez Sanz Ruben, van Hooydonk Elving Jolanda, Jääskeläinen Anne, Jancskaite Ruta, Keeren Kathrin, Fischer Thea, Krokstad Sidsel, Nikolaeva-Glomb Lubomira, Novakova Ludmila, Midgley Sofie, Mirand Drey, Molenkamp Richard, Morley Ursula, Mossong Joël, Muralyte Svajune, Murk Jean,Luc, Nguyen Trung, Nordbø Svein, Österback Riikka, Pas Suzan, Pellegrinelli Lra, Pogka Vassiliki, Prochazka Birgit, Rainetova Petra, Van Ranst Marc, Roorda Lieuwe, Schuffenecker Isabelle, Schuurman Rob, Stoyanova Asya, Templeton Kate, Verweij Jaco, Voulgari,Kokota Androniki, Vuorinen Tytti, Wollants Elke, Wolthers Katja, Zakikhany Katherina, Neher Richard, Harvala Heli, Simmonds Peter
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories (2021)

Journal of Clinical Microbiology
Wegner Fanny, Roloff Tim, Huber Michael, Cordey Samuel, Ramette Alban, Gerth Yannick, Bertelli Claire, Stange Madlen, Seth-Smith Helena MB, Mari Alfredo, Leuzinger Karoline, Cerutti Lorenzo, Harshman Keith, Xenarios Ioannis, Le Mercier Philippe, Bittel Pascal, Neuenschwander Stefan, Opota Onya, Fuchs Jonas, Panning Marcus, Michel Charlotte, Hallin Marie, Demuyser Thomas, De Mendonca Ricardo, Savelkoul Paul, Dingemans Jozef, van der Veer Brian, Boers Stefan A, Claas Eric CJ, Coolen Jordy PM, Melchers Willem JG, Gunell Marianne, Kallonen Teemu, Vuorinen Tytti, Hakanen Antti J, Bernhoff Eva, Hetland Marit Andrea Klokkhammer, Berman Hadar Golan, Adar Sheera, Moran-Gilad Jacob, Wolf Dana G, Leib Stephen L, Nolte Oliver, Kaiser Laurent, Schmutz Stefan, Kufner Verena, Zaheri Maryam, Trkola Alexandra, Aamot Hege V, Hirsch Hans H, Greub Gilbert, Egli Adrian
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021 (2021)

Eurosurveillance
Benschop KSM, Albert J, Anton A, Andres C, Aranzamendi M, Armannsdottir B, Bailly JL, Baldanti F, Baldvinsdottir GE, Beard S, Berginc N, Bottcher S, Blomqvist S, Bubba L, Calvo C, Cabrerizo M, Cavallero A, Celma C, Ceriotti F, Costa I, Cottrell S, del Cuerpo M, Dean J, Dembinski JL, Diedrich S, Diez-Domingo J, Dorenberg D, Duizer E, Dyrdak R, Fanti D, Farkas A, Feeney S, Flipse J, De Gascun C, Galli C, Georgieva I, Gifford L, Guiomar R, Honemann M, Ikonen N, Jeannoel M, Josset L, Keeren K, Lopez-Labrador FX, Maier M, McKenna J, Meijer A, Mengual-Chulia B, Midgley SE, Mirand A, Montes M, Moore C, Morley U, Murk JL, Nikolaeva-Glomb L, Numanovic S, Oggioni M, Palminha P, Pariani E, Pellegrinelli L, Piralla A, Pietsch C, Pineiro L, Rabella N, Rainetova P, Renteria SCU, Romero MP, Reynders M, Roorda L, Savolainen-Kopra C, Schuffenecker I, Soynova A, Swanink CM, Ursic T, Verweij JJ, Vila J, Vuorinen T, Simmonds P, Fischer TK, Harvala H
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))